CSR Pharma Group (ChemSun Research) is collaborating with Rutgers University on a New Jersey Economic Development Authority-funded pilot study of a biological platform for genome-associated precision therapies in glioblastoma, using a mouse xenograft model.
The company’s corporate culture promotes innovation, quality, commitment and social responsibility. Its credentials include scientific research training from the U.S. National Institutes of Health (NIH) and many years of practical experience in healthcare companies.
CSR Pharma Group is located at 991 US Highway 22 West, Suite 200, Bridgewater, NJ 08807. The page lists the company’s telephone and fax numbers, business development and career opportunity email addresses, and a contact form.
CSR Pharma Group, Inc. researches, develops and commercializes therapies and healthcare solutions for difficult-to-treat diseases with unmet medical needs or limited patient options.